In a parallel study, we explored the efficacy of IL-4 as an adjuvant in DC-mediated vaccination as in the context of visceral leishmaniasis, IL-4 mediates protective immunity and has been shown to instruct successful chemotherapy and vaccination responses (80). Here, IL4 is linked to visceral leishmaniasis.